News

Verano Holdings Reports 2024 Q4 & Annual Financial Performances

Verano Holdings Reports 2024 Q4 & Annual Financial Performances

Financial Results Overview for Verano Holdings

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), a prominent player in the cannabis industry, has successfully published its financial results for the fourth quarter and entire year of 2024. These results underline the company's commitment to growth and innovation in a rapidly changing industry.

Quarterly and Yearly Financial Highlights

Fourth Quarter Financial Highlights

  • Quarterly revenues report net of discounts reached $218 million, indicating an 8% decrease year-over-year but a slight increase of 1% compared to the previous quarter.
  • Gross profit amounted to $108 million, marking 49% of total revenue.
  • Sales, General, and Administrative (SG&A) expenses were reported at $84 million, which is 38% of revenue.
  • The net loss for this period stood at $273 million or 125% of revenue.
  • Adjusted EBITDA was recorded at $63 million, representing 29% of revenue.
  • The company generated $44 million in cash from operating activities during the quarter.
  • Capital expenditures totaled $14 million.

Annual Financial Overview

  • For the year, net revenues tallied up to $879 million, which was a 6% decline compared to the previous year.
  • Gross profit for the year was $444 million or 51% of revenue.
  • SG&A expenses totaled $353 million, which accounted for 40% of total revenue.
  • The company's net loss was $342 million, equating to 39% of revenue.
  • Adjusted EBITDA for the year came in at $264 million or 30% of revenues.
  • Operating activities produced a net cash inflow of $112 million for the year.
  • Capital expenditures amounted to $99 million.

Insights from Management

George Archos, founder and CEO of Verano, expressed profound pride in the team's resilience throughout 2024, which laid a strong foundation to enhance core business operations and pursue future growth. "In a dynamic context, we have successfully established our presence in new markets, including Virginia, and ramped up operations in existing regions like Arizona," Archos added.

Strategies for Continued Growth

Looking forward, Verano is focused on harnessing innovation and operational excellence. Archos emphasizes the importance of speed and adaptability in the mission to grow Verano into a leading cannabis enterprise that prioritizes quality and customer satisfaction. This focus spans across various sectors of the business, ensuring robust offerings that cater to consumer demands.

Fourth Quarter Financial Breakdown

Delving deeper into Q4, the reported revenue reflects fluctuations driven by price pressures and promotional activities in key markets. The gross profit holds significant value at 49% of revenue, yet shows a dip from previous periods primarily due to revenue contraction. Verano has optimized its operating expenses effectively, reducing SG&A through strategic operational efficiencies.

Financial Guidance for 2025

  • Verano anticipates capital expenditures ranging from $25 to $40 million in 2025, reflecting a cautious yet optimistic approach towards expansion and market penetration.

Operational Achievements in Q4

  • Launched the "Save the BITS" campaign, uniting dispensaries across states to support breast cancer research.
  • Initiated adult use sales at Zen Leaf Waterbury, converting existing dispensaries into a dual sales model.
  • Broadened operational reach with new dispensary openings, elevating the brand's footprint in New Jersey.
  • Responded positively to consumer trends by introducing innovative products across fast-growing categories.

Subsequent Developments

  • In January, Verano strategically terminated certain retail agreements and successfully sold specific leased properties.
  • The company has continued to expand its presence, with new openings in Florida enhancing their operational capacity and retail presence.
  • Active operations now span 13 states, maintaining a comprehensive network of 153 dispensaries and 15 production facilities.

Current Financial Health

As of year-end 2024, Verano's balance sheet shows strong liquidity with $358 million in current assets, including $88 million in cash. A working capital of $160 million indicates robust financial health, while total debts sum up to $414 million.

Engagement with Stakeholders

A conference call is scheduled to delve further into these results, allowing analysts and investors a chance to engage with the Verano leadership to discuss strategies and outlook.

Frequently Asked Questions

What financial results did Verano report for Q4 2024?

Verano reported revenues of $218 million with a net loss of $273 million in Q4 2024.

What are the significant changes in Verano's annual financial highlights?

Overall revenue for 2024 was $879 million, down 6% from the previous year, with gross profit at 51% of revenue.

What strategies is Verano adopting for future growth?

Verano aims to leverage innovation and automation to enhance growth and adapt to consumer demands in the cannabis sector.

What operational achievements did Verano realize in Q4 2024?

Verano launched new retail operations, entered new markets, and introduced several innovative products based on market trends.

What financial guidance has Verano provided for 2025?

Verano anticipates capital expenditures between $25 and $40 million for 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading